243 related articles for article (PubMed ID: 9765320)
1. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig.
McLeod RL; Aslanian R; del Prado M; Duffy R; Egan RW; Kreutner W; McQuade R; Hey JA
J Pharmacol Exp Ther; 1998 Oct; 287(1):43-50. PubMed ID: 9765320
[TBL] [Abstract][Full Text] [Related]
2. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
[TBL] [Abstract][Full Text] [Related]
5. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
Garbarg M; Arrang JM; Rouleau A; Ligneau X; Tuong MD; Schwartz JC; Ganellin CR
J Pharmacol Exp Ther; 1992 Oct; 263(1):304-10. PubMed ID: 1383495
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
[TBL] [Abstract][Full Text] [Related]
7. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
Endou M; Poli E; Levi R
J Pharmacol Exp Ther; 1994 Apr; 269(1):221-9. PubMed ID: 8169830
[TBL] [Abstract][Full Text] [Related]
8. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug.
Rouleau A; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 2000 Oct; 295(1):219-25. PubMed ID: 10991982
[TBL] [Abstract][Full Text] [Related]
10. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
11. [Presynaptic histamine H3-receptors exist on cardiac sympathetic terminals of guinea pig].
Luo XX
Sheng Li Ke Xue Jin Zhan; 1995 Jul; 26(3):233-6. PubMed ID: 8584890
[TBL] [Abstract][Full Text] [Related]
12. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
[TBL] [Abstract][Full Text] [Related]
13. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
Garduño-Torres B; Arias-Montaño JA
Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
[TBL] [Abstract][Full Text] [Related]
14. The role of histamine H1, H2 and H3 receptors on enteric ascending synaptic transmission in the guinea pig ileum.
Izzo AA; Costa M; Mascolo N; Capasso F
J Pharmacol Exp Ther; 1998 Dec; 287(3):952-7. PubMed ID: 9864278
[TBL] [Abstract][Full Text] [Related]
15. Production by R-alpha-methylhistamine of a histamine H3 receptor-mediated decrease in basal vascular resistance in guinea-pigs.
McLeod RL; Gertner SB; Hey JA
Br J Pharmacol; 1993 Oct; 110(2):553-8. PubMed ID: 7902173
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological approach of histamine H3 receptors: use of arterial and bronchiolar perfusion technique].
Oudart N; Kim LE; Burgaud JL
Ann Pharm Fr; 1996; 54(5):217-22. PubMed ID: 8953796
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sympathetic hypertensive responses in the guinea-pig by prejunctional histamine H3-receptors.
Hey JA; del Prado M; Egan RW; Kreutner W; Chapman RW
Br J Pharmacol; 1992 Oct; 107(2):347-51. PubMed ID: 1330174
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
Mezzomo K; Cumming P; Minuzzi L
Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.
Rouleau A; Garbarg M; Ligneau X; Mantion C; Lavie P; Advenier C; Lecomte JM; Krause M; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 1997 Jun; 281(3):1085-94. PubMed ID: 9190840
[TBL] [Abstract][Full Text] [Related]
20. UK-14,304, R(-)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms.
Matsubara T; Moskowitz MA; Huang Z
Eur J Pharmacol; 1992 Dec; 224(2-3):145-50. PubMed ID: 1281776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
